SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-10-030368
Filing Date
2010-03-31
Accepted
2010-03-31 07:04:09
Documents
7
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K c98562e10vk.htm 10-K 650212
2 EXHIBIT 10.25 c98562exv10w25.htm EX-10.25 344764
3 EXHIBIT 23.1 c98562exv23w1.htm EX-23.1 1438
4 EXHIBIT 31.1 c98562exv31w1.htm EX-31.1 8476
5 EXHIBIT 31.2 c98562exv31w2.htm EX-31.2 8736
6 EXHIBIT 32.1 c98562exv32w1.htm EX-32.1 4020
7 EXHIBIT 32.2 c98562exv32w2.htm EX-32.2 4097
  Complete submission text file 0000950123-10-030368.txt   1023287
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-15070 | Film No.: 10715928
SIC: 2834 Pharmaceutical Preparations